CH647749A5 - Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. - Google Patents

Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. Download PDF

Info

Publication number
CH647749A5
CH647749A5 CH5736/80A CH573680A CH647749A5 CH 647749 A5 CH647749 A5 CH 647749A5 CH 5736/80 A CH5736/80 A CH 5736/80A CH 573680 A CH573680 A CH 573680A CH 647749 A5 CH647749 A5 CH 647749A5
Authority
CH
Switzerland
Prior art keywords
monacolin
monascus
sank
salts
group
Prior art date
Application number
CH5736/80A
Other languages
German (de)
English (en)
Inventor
Yoshio Tsujita
Masao Kuroda
Kazuhiko Tanzawa
Seigo Iwado
Kiyoshi Hamano
Akira Terahara
Sadao Sato
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9581479A external-priority patent/JPS5621594A/ja
Priority claimed from JP12346179A external-priority patent/JPS5646841A/ja
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of CH647749A5 publication Critical patent/CH647749A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH5736/80A 1979-07-27 1980-07-25 Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate. CH647749A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9581479A JPS5621594A (en) 1979-07-27 1979-07-27 Mb-530b carboxylic acid metal salt and its preparation
JP12346179A JPS5646841A (en) 1979-09-26 1979-09-26 Mb-530b carboxylic acid ester and its preparation

Publications (1)

Publication Number Publication Date
CH647749A5 true CH647749A5 (de) 1985-02-15

Family

ID=26436995

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5736/80A CH647749A5 (de) 1979-07-27 1980-07-25 Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate.

Country Status (16)

Country Link
AT (1) AT375334B (it)
AU (1) AU6083980A (it)
CH (1) CH647749A5 (it)
DD (1) DD153827A5 (it)
DE (1) DE3028284A1 (it)
DK (1) DK322380A (it)
ES (1) ES8105781A1 (it)
FI (1) FI71300C (it)
FR (1) FR2462417A1 (it)
GB (1) GB2055100A (it)
IT (1) IT1147763B (it)
NL (1) NL8004303A (it)
NO (1) NO156210C (it)
NZ (1) NZ194445A (it)
PL (1) PL225901A1 (it)
SE (1) SE445828B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
CA1282425C (en) * 1984-06-04 1991-04-02 Meyer Sletzinger Process for preparing hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit
EP0204287A3 (en) * 1985-06-04 1987-07-01 Merck & Co. Inc. Process for the preparation of hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit
US4611081A (en) * 1985-07-05 1986-09-09 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
USRE33033E (en) * 1985-07-05 1989-08-22 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
JP2002518448A (ja) * 1998-06-24 2002-06-25 メルク エンド カムパニー インコーポレーテッド 高血中コレステロールを治療する組成物および方法
SI20070A (sl) 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nove soli inhibitorjev HMG-CoA reduktaze
SI1292293T1 (en) * 2000-06-09 2004-06-30 LEK farmacevtska dru�ba d.d. Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
US6806290B2 (en) 2000-06-09 2004-10-19 Lek Pharmaceuticals D.D. Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
AU2001288724A1 (en) * 2000-09-06 2002-03-22 Merck & Co., Inc. Dihydroxy open-acid salt of simvastatin
JP2005500282A (ja) 2001-06-13 2005-01-06 ランバクシー ラボラトリーズ リミテッド 新規なHMG−CoAレダクターゼ抑制剤としてのシムバスタチンのメチル同族体
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
CN101659923B (zh) * 2008-08-26 2011-10-26 北京北大维信生物科技有限公司 一种制备开环式洛伐他汀的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137322A (en) * 1976-11-02 1979-01-30 Sankyo Company Limited ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b

Also Published As

Publication number Publication date
GB2055100A (en) 1981-02-25
NL8004303A (nl) 1981-01-29
DE3028284A1 (de) 1981-02-19
ES493726A0 (es) 1981-06-16
FR2462417B1 (it) 1984-01-20
FI71300B (fi) 1986-09-09
SE445828B (sv) 1986-07-21
DK322380A (da) 1981-01-28
NO156210C (no) 1987-08-12
SE8005386L (sv) 1981-01-28
AT375334B (de) 1984-07-25
PL225901A1 (it) 1982-07-19
DD153827A5 (de) 1982-02-03
IT1147763B (it) 1986-11-26
ES8105781A1 (es) 1981-06-16
FI802357A (fi) 1981-01-28
AU6083980A (en) 1981-01-29
ATA392380A (de) 1983-12-15
FI71300C (fi) 1986-12-19
DE3028284C2 (it) 1990-08-09
NZ194445A (en) 1984-07-06
NO802244L (no) 1981-01-28
IT8068211A0 (it) 1980-07-28
FR2462417A1 (fr) 1981-02-13
NO156210B (no) 1987-05-04

Similar Documents

Publication Publication Date Title
DE3242849C2 (it)
CH645891A5 (de) Verfahren zur herstellung von monacolin k.
DE3006216C2 (de) Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE2634499C2 (de) Tylosin-Acylderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen und Tierfutterzubereitungen
DE2524355A1 (de) Physiologisch aktive verbindungen und verfahren zu ihrer herstellung
CH647749A5 (de) Salze und ester von monacolin-k, verfahren zu ihrer herstellung und pharmazeutische praeparate.
DE60003424T2 (de) Hydroxylierung von compactin zu pravastatin unter verwendung von micromonospora bakterien
DE4320023A1 (de) Holotyp-Stamm Aspergillus obscurus und Verfahren zur Herstellung von µ,£-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{methyl}-butyryloxy)-naphthalin-1-yl]-heptansäure-£-lacton{Mevinolin} und/oder µ,5-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{mehtyl}-butyryloxy)-naphthalin-1-yl]-heptansäure
DE60019898T2 (de) Mikrobielles verfahren zur herstellung von pravastatin
CH568386A5 (en) Antifungal antibiotic A32204 prodn - by aerobic cultivation of Aspergillus nidulans var. echinulatus A32204
DE2849696A1 (de) Verfahren zur herstellung des antibiotikums c-15003 p-3
DE2035814C3 (de) Pleuromutilin-Derivate, Verfahren zu ihrer Herstellung und Verwendung
DE3114242A1 (de) Carbonsaeurederivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE69908569T2 (de) Verfahren zur herstellung von fexofenadin
EP0133971B1 (de) Antibiotikum, dessen Herstellung sowie dessen Verwendung
DE2120930A1 (de) Pepsin-Inhibitor und Verfahren zu dessen Herstellung
DE2209067A1 (de) Neue Antibiotika, ihre Herstellung und die medizinischen Zusammensetzungen, die sie enthalten
DE2839668A1 (de) Als antibiotika wirksame saframycine a, b, c, d und e und verfahren zu ihrer herstellung
CH640269A5 (de) Verfahren zur herstellung des antibiotikums c-15003 p-4.
EP0482543B1 (de) Oasomycine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3051206C2 (de) Verfahren zur fermentativen Herstellung von Monacolin K
DE3881566T2 (de) Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE2510868C3 (de) Nanaomycin A und Verfahren zur Herstellung der Antibiorica Nanaomycin A und Nanaomycin B
DE946256C (de) Verfahren zur Herstellung und Gewinnung eines Antibiotikums
DE1518352C (de) Basisch in 1 Stellung substituierte Xanthen oder Thioxanthendenvate und Ver fahren zu ihrer Herstellung

Legal Events

Date Code Title Description
PL Patent ceased